Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Paul Billings: May 7, 2014

Premium

Genome interpretation firm Omicia has hired Paul Billings as its new chief medical officer. Billings will also serve on the firm's scientific advisory board.

He comes to Omicia from Life Technologies, which was acquired by Thermo Fisher Scientific and where he was chief medical officer. Before that, Billings was chief scientific officer of the Genomic Medicine Institute at El Camino Hospital, and CEO of CELLective Dx Corporation. Billings is a genomics industry leader and has held executive-level positions at numerous top life sciences firms and organizations.

Filed under

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.